Skip the rush later

Complete your consultation ahead of launch and our clinicians will check whether treatment is safe and suitable for you before the pills become available.


Your pre-order will be shipped once stock arrives early July 2026
We'll alert you the moment Wegovy pills are in stock.
Wegovy pills are an oral semaglutide medication used to support weight loss by helping you regulate your appetite and food intake. They are designed for people who want medical support without injections.
The active ingredient is semaglutide, a GLP-1 receptor agonist that mimics hormones involved in appetite control. Semaglutide, whether in tablets or an injectable pen, works by: reducing hunger signals in your brain slowing how quickly your stomach empties helping you feel fuller for longer
To be eligible for Wegovy pills, you'll need a a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related health condition like type 2 diabetes or high cholesterol. You'll also need to complete a consultation so we can confirm the treatment is suitable for you.

Complete your consultation ahead of launch and our clinicians will check whether treatment is safe and suitable for you before the pills become available.

Once approved, there’s nothing left to hold things up. As soon as they are available, we can send your treatment straight to your door.

Thinking about switching from another treatment? Wondering how it works? Our team is here to answer questions and help you feel confident before starting treatment.
Wegovy pills are an oral semaglutide medication used to support weight loss by helping you regulate your appetite and food intake. They are designed for people who want medical support without injections.
The active ingredient is semaglutide, a GLP-1 receptor agonist that mimics hormones involved in appetite control.
Semaglutide, whether in tablets or an injectable pen, works by:
In the Wegovy pill, semaglutide is combined with a 'carrier molecule' which helps the medication get into your bloodstream through your stomach.
During the 2025 OASIS 4 trial looking at the effects of oral semaglutide on people with overweight or obesity, it was shown that patients on average lost 17% of their starting body weight while on Wegovy tablets.
However, early responders during (those that lost more than 10% of their starting weight by week 16) saw an average weight loss of 22% by the end of the trial.
This compares to the average weight loss of 21% seen on Wegovy injections.
Weight loss | Percentage |
|---|---|
Average weight loss during clinical trials | 17% |
Average weight loss for early responders during clinical trials | 22% |
Patients who lost at least 5% of their starting weight | 76% |
Patients who lost at least 10% of their starting weight | 60% |
Patients who lost at least 15% of their starting weight | 47% |
Patients who lost 20% or more | 28% |
However, overall weight loss varies depending on:
The eligibility requirements for Wegovy pills are the same for injections. You’ll need:
Once they’re available to order, you’ll need to complete a consultation so we can assess if the treatment is a good fit for you.
The available doses of Wegovy tablets are as follows:
Dose | Duration |
|---|---|
1.5mg once a day | Days 1 to 30 |
4mg once a day | Days 31 to 60 |
9mg once a day | Days 61 to 90 |
25mg once a day | Day 91 onwards |
As with Wegovy injections, patients are recommended to gradually increase their dose over time, so you can get used to the medication.
Yes, you can switch from Wegovy injections to Wegovy pills. However, you should only do so under clinical supervision. We offer the following guidance for switching between the two treatments:
Wegovy injection dose | Wegovy pills dose |
|---|---|
0.25mg | 4mg |
0.5mg | 4mg |
1mg | 4mg, or 9mg if you had no side effects on the 1mg injection |
1.7mg | 9mg |
2.4mg | 25mg |
If you're on Wegovy 7.2mg, it's possible to switch to the 25mg tablets. While the tablets are slightly less effective than the maximum injectable dose, they are more effective than 2.4mg, and may be a better, more convenient fit for your routine, especially as a maintenance dose.
If you're taking Mounjaro and thinking about switching to Wegovy pills, you should only do so under clinical guidance. Our current dose recommendation, once the tablets are available, is:
Mounjaro injection dose | Wegovy pills dose |
|---|---|
2.5mg | 4mg |
5mg | 4mg |
7.5mg | 9mg |
10mg | 9mg |
12.5mg | 9mg |
15mg | 25mg |
However, always speak with your prescribing pharmacist before switching or stopping any medication.
We currently don’t know how much Wegovy tablets will cost in the UK. The price of the treatment will depend on the price Novo Nordisk sets for the UK market, how available they are, and the dose you end up taking.
Strength | Price |
|---|---|
1.5mg | £99.00 |
4mg | £99.00 |
9mg | £119.00 |
25mg | £199.00 |
Your pre-order will be shipped once stock arrives in July 2026
Wegovy tablets are taken once daily, on an empty stomach after waking up, with a sip of water.
You should then wait 30 minutes before eating, drinking, or taking any other oral medications.
The manufacturer states that if a dose of Wegovy tablets is missed, the dose should be skipped, and to resume the scheduled dose the next day.
Common side effects noted in clinical trials included:
The manufacturer currently advises patients to seek urgent advice if they experience:
No. Rybelsus is an oral semaglutide medication approved for type 2 diabetes, not specifically for weight loss.
While both contain semaglutide, they have different uses in clinical trials, different maximum doses, and Wegovy is not currently licensed in the UK.
Yes, Wegovy pills are available to pre-order in the UK after being approved by the MHRA on 11 June 2026.
Wegovy tablets work best when combined with lifestyle changes. Treatment can help reduce appetite, but long-term success comes from sustainable habits.
Clinical trials data showed that some people notice reduced appetite within weeks of starting Wegovy tablets, but meaningful weight loss typically developed over several months.
“Wegovy tablets offer a needle-free approach to weight loss, expanding the number of people who can access life-changing treatment. Pills can help patients manage their appetites and build healthier habits while providing an option that may be easier to fit into their everyday life.”
Ayesha Bashir, weight loss expert at myBMI
Calculate your Body Mass Index to understand your weight category

We're committed to your safety and wellbeing

All clincal assessments and medication prescribed is via myBMIs clinical team, including James O’Loan (GPhC: 2084549), Lou Humphreys (GPhC: 2049466) John Campbell (GPhC: 2069835) Ian Budd (GPhC: 2037876) Celina Mark (GPhC: 2216421) and Ayesha Bashir (GPhC: 2209645) who are all General Pharmaceutical Council (GPhC) registered, ensuring full compliance with professional requirements for GPhC prescribing. myBMI is also regulated via its partnership with its dispensing pharmacy Innox Trading Ltd, (t/a Chemist4U), which is registered with the GPhC under number 9012464.
If you’ve got questions, we’re here to help. If you can’t find the answer you’re looking for, our customer support team is always on hand to offer guidance and support.